Bayer, the German chemical and pharmaceutical company, said Tuesday it was starting to integrate Creve Coeur-based seed and chemical producer Monsanto into its corporate structure.
Bayer became Monsanto’s sole owner in June, but the companies had to delay fully combining until completing divestments required to gain regulatory clearance for the $63 billion deal.
The acquisition was initially announced in September 2016, marking part of a trend toward consolidation between major players in the agribusiness industry.
Liam Condon, president of Bayer’s Crop Science division, called the combination a milestone that will lead to “breakthrough innovation” in agriculture.
Read more: St. Louis Post-Dispatch